HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA budget

This article was originally published in The Rose Sheet

Executive Summary

Senate passes $1.18 bil. in FDA FY 2000 funding as part of $68.1 bil. Agriculture appropriations bill by voice vote Aug. 4. Under the bill (S 1233), The Center for Food Safety & Applied Nutrition, which includes the Office of Cosmetics & Colors in funding, will receive $264.8 mil., while the Center for Drug Evaluation & Research receives $309 mil. The allocations fall below both the House and the Clinton Administration requests to allocate $266 mil. to CFSAN and $316.8 mil. to CDER

You may also be interested in...



FDA appropriations

Agriculture appropriations bill S 1233 provides the Office of Cosmetics & Colors with the same level of funding for FY 2000 as in FY 1999. The budget is part of the $264.8 mil. allotted for the Center for Food Safety & Applied Nutrition (1"The Rose Sheet" Aug. 9, In Brief)

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006986

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel